Cargando…

Clinical application value of expanded carrier screening in the population of childbearing age

OBJECTIVE: The objective of this study was to explore the clinical utility of the implementation of expanded carrier screening (ECS) in Chinese population of childbearing age. MATERIALS AND METHODS: Based on capillary electrophoresis, a first-generation sequencing technology, a prospective screening...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Yuqin, Li, Jingran, Zhang, Miaomiao, Cheng, Yuan, Wang, Chaohong, Zhu, Jiansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082524/
https://www.ncbi.nlm.nih.gov/pubmed/37031186
http://dx.doi.org/10.1186/s40001-023-01112-8
_version_ 1785021330869977088
author Fang, Yuqin
Li, Jingran
Zhang, Miaomiao
Cheng, Yuan
Wang, Chaohong
Zhu, Jiansheng
author_facet Fang, Yuqin
Li, Jingran
Zhang, Miaomiao
Cheng, Yuan
Wang, Chaohong
Zhu, Jiansheng
author_sort Fang, Yuqin
collection PubMed
description OBJECTIVE: The objective of this study was to explore the clinical utility of the implementation of expanded carrier screening (ECS) in Chinese population of childbearing age. MATERIALS AND METHODS: Based on capillary electrophoresis, a first-generation sequencing technology, a prospective screening study of carriers of 15 single-gene diseases was carried out in 327 subjects in Anhui Province, including 84 couples and 159 women of childbearing age, the disease carrier rate, types of screened pathogenic genes, and incidence of both partners carrying the same pathogenic genes were summarized and analyzed. RESULTS: In 320 people with normal phenotypes who underwent ECS for 15 genetic diseases and 7 spouses who underwent targeted gene sequencing, 65 carriers of at least one disease were detected, with a total carrier rate of 20.31% (65/320). Among the 65 carriers, 81.54% (53/65) carried one genetic variant, 16.92% (11/65) carried two genetic variants, and 1.54% (1/65) carried three genetic variants. In this study, the three diseases with the highest carrier rates were hereditary deafness (8.13%, 26/320), Wilson's disease (4.06%, 13/320), and phenylketonuria (3.13%, 10/320). One high-risk couple (1.19%, 1/84) was detected. CONCLUSIONS: It has certain clinical application value to implement ECS in the population of childbearing age in China.
format Online
Article
Text
id pubmed-10082524
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100825242023-04-09 Clinical application value of expanded carrier screening in the population of childbearing age Fang, Yuqin Li, Jingran Zhang, Miaomiao Cheng, Yuan Wang, Chaohong Zhu, Jiansheng Eur J Med Res Research OBJECTIVE: The objective of this study was to explore the clinical utility of the implementation of expanded carrier screening (ECS) in Chinese population of childbearing age. MATERIALS AND METHODS: Based on capillary electrophoresis, a first-generation sequencing technology, a prospective screening study of carriers of 15 single-gene diseases was carried out in 327 subjects in Anhui Province, including 84 couples and 159 women of childbearing age, the disease carrier rate, types of screened pathogenic genes, and incidence of both partners carrying the same pathogenic genes were summarized and analyzed. RESULTS: In 320 people with normal phenotypes who underwent ECS for 15 genetic diseases and 7 spouses who underwent targeted gene sequencing, 65 carriers of at least one disease were detected, with a total carrier rate of 20.31% (65/320). Among the 65 carriers, 81.54% (53/65) carried one genetic variant, 16.92% (11/65) carried two genetic variants, and 1.54% (1/65) carried three genetic variants. In this study, the three diseases with the highest carrier rates were hereditary deafness (8.13%, 26/320), Wilson's disease (4.06%, 13/320), and phenylketonuria (3.13%, 10/320). One high-risk couple (1.19%, 1/84) was detected. CONCLUSIONS: It has certain clinical application value to implement ECS in the population of childbearing age in China. BioMed Central 2023-04-08 /pmc/articles/PMC10082524/ /pubmed/37031186 http://dx.doi.org/10.1186/s40001-023-01112-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Fang, Yuqin
Li, Jingran
Zhang, Miaomiao
Cheng, Yuan
Wang, Chaohong
Zhu, Jiansheng
Clinical application value of expanded carrier screening in the population of childbearing age
title Clinical application value of expanded carrier screening in the population of childbearing age
title_full Clinical application value of expanded carrier screening in the population of childbearing age
title_fullStr Clinical application value of expanded carrier screening in the population of childbearing age
title_full_unstemmed Clinical application value of expanded carrier screening in the population of childbearing age
title_short Clinical application value of expanded carrier screening in the population of childbearing age
title_sort clinical application value of expanded carrier screening in the population of childbearing age
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082524/
https://www.ncbi.nlm.nih.gov/pubmed/37031186
http://dx.doi.org/10.1186/s40001-023-01112-8
work_keys_str_mv AT fangyuqin clinicalapplicationvalueofexpandedcarrierscreeninginthepopulationofchildbearingage
AT lijingran clinicalapplicationvalueofexpandedcarrierscreeninginthepopulationofchildbearingage
AT zhangmiaomiao clinicalapplicationvalueofexpandedcarrierscreeninginthepopulationofchildbearingage
AT chengyuan clinicalapplicationvalueofexpandedcarrierscreeninginthepopulationofchildbearingage
AT wangchaohong clinicalapplicationvalueofexpandedcarrierscreeninginthepopulationofchildbearingage
AT zhujiansheng clinicalapplicationvalueofexpandedcarrierscreeninginthepopulationofchildbearingage